Holoclara raises $16 million in Series A funding led by Bold Capital Partners to develop therapeutics using worms
Jun 27, 2024•over 1 year ago
Amount Raised
$16 Million
Round Type
series a
Los AngelesBiotechnologyHealth CareInvestors
Kairos VenturesFreeflow VenturesEndurance28TarrasqueHorizons VenturesBold Capital Partners
Description
Biotech startup Holoclara has raised $16 million for its Series A. The funding round was led by Bold Capital Partners, with participation from Horizons Ventures, Tarrasque, Endurance28, Freeflow Ventures, and several angel investors. The company aims to develop therapeutics using worms, which have shown potential in alleviating conditions like asthma.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech